Candel Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Candel Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 23, 2026, to elect directors and ratify auditor appointment.
NASDAQ
Candel Therapeutics, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Candel Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on June 17, 2025, to elect directors and ratify the appointment of KPMG LLP as its independent accounting firm.
NASDAQ
Candel Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on June 26, 2024, to elect directors and ratify the appointment of KPMG LLP as its independent accounting firm.